From promise to compliance: The development of 'integrity' at SmithKline Beecham

被引:1
作者
Jones, IW [1 ]
Pollitt, MG
机构
[1] Univ Exeter, Exeter EX4 4QJ, Devon, England
[2] Univ Cambridge, Cambridge CB2 1TN, England
关键词
D O I
10.1016/S0024-6301(99)00017-5
中图分类号
F [经济];
学科分类号
02 ;
摘要
This paper contains a case study of how SmithKline Beecham (SB), an Angle-American pharmaceutical company, has gone about bloodstreaming its 'integrity' value in the context of its overall development of a value-driven corporate culture. SB was formed as a result of a 'merger of equals' in 1989 and has developed and implemented a new set of values since then, We provide an analysis of the success of SB's development of an integrity value and suggest lessons for other companies from the process. (C) 1999 Published by Elsevier Science Ltd, Ail rights reserved.
引用
收藏
页码:190 / 198
页数:9
相关论文
共 50 条
[41]   SmithKline Beecham's drug-testing lab in Atlanta [J].
Chemical & Engineering News, 1996, 74 (26)
[42]   Merger of Glaxo Wellcome and SmithKline Beecham creates pharmaceutical giant [J].
Abbott, A .
NATURE, 2000, 403 (6767) :232-232
[43]   Glaxo Wellcome and SmithKline Beecham to merge in £100b deal [J].
不详 .
CHEMICAL ENGINEER-LONDON, 1998, (651) :4-4
[45]   SmithKline Beecham funds Stanford University Program in Genomics, Ethics, and Society [J].
不详 .
BIOTECHNOLOGY LAW REPORT, 1996, 15 (01) :62-62
[47]   How SmithKline Beecham makes better resource-allocation decisions [J].
Sharpe, P ;
Keelin, T .
HARVARD BUSINESS REVIEW, 1998, 76 (02) :45-+
[48]   SmithKline Beecham's Atlanta lab gears up for Olympic drug testing [J].
Zurer, PS .
CHEMICAL & ENGINEERING NEWS, 1996, 74 (26) :28-29